The introduction of the absolute risk for the detection of fetal aneuploidies in the first-trimester screening

References

• Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005;29:190–4
   PubMed Web of Science ®Google Scholar
• Schmidt P, Hörmansdörfer C, Golatta M, et al. Analysis of the distribution shift of detected aneuploidies by age independent first trimester screening. Arch Gynecol Obstet 2010;281:393–9
   PubMed Web of Science ®Google Scholar
• Schmidt P, Rom J, Maul H, et al. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations. Arch Gynecol Obstet 2007;276:159–66
   PubMedGoogle Scholar
• Hörmansdörfer C, Schmidt P, Hillemanns P, et al. The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides. Z Für Geburtshilfe Neonatol 2007;211:243–9
   PubMedGoogle Scholar
• Engels MAJ, Heijboer AC, Blankenstein MA, et al. Performance of first-trimester combined test for Down syndrome in different maternal age groups: reason for adjustments in screening policy? Prenat Diagn 2011;31:1241–5
   PubMed Web of Science ®Google Scholar
• Reynolds TM, Nix AB, Dunstan FD, et al. Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening. Obstet Gynecol 1993;81:447–50
   PubMed Web of Science ®Google Scholar
• Egan JF, Benn P, Borgida AF, et al. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000;96:979–85
   PubMed Web of Science ®Google Scholar
• Spencer K. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A. BJOG 2001;108:1043–6
   PubMed Web of Science ®Google Scholar
• Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405–13
   PubMed Web of Science ®Google Scholar
• Padula F, Cignini P, Giannarelli D, et al. Retrospective study evaluating the performance of a first-trimester combined screening for trisomy 21 in an Italian unselected population. J Prenat Med 2014;8:50–6
   PubMedGoogle Scholar
• Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867–9
   PubMed Web of Science ®Google Scholar
• Kublickas M, Crossley J, Aitken D. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system. Acta Obstet Gynecol Scand 2009;88:635–8. 7p following 638
   PubMed Web of Science ®Google Scholar
• Robinson HP. Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy. Br Med J 1973;4:28–31
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Chalouhi GE, Bernard J-P, et al. Nuchal translucency thickness at 11–14 weeks of gestation: French charts and equations. J Gynécologie Obstétrique Biol Reprod 2009;38:635–41
   PubMed Web of Science ®Google Scholar
• Spencer K, Bindra R, Cacho AM, et al. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004;24:169–73
   PubMed Web of Science ®Google Scholar
• Liao AW, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001;16:1501–4
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Sundberg K, Holzgreve W, et al. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999;13:167–70
   PubMed Web of Science ®Google Scholar
• Spencer K, Ong CY, Liao AW, et al. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 2000;20:491–4
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Spencer CE, et al. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2010;30:937–40
   PubMed Web of Science ®Google Scholar
• Spencer K, Souter V, Tul N, et al. A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231–7
   PubMed Web of Science ®Google Scholar
• Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27:1–7
   PubMed Web of Science ®Google Scholar
• Hartwig TS, Sørensen S, Jørgensen FS. Are there characteristics of the false-negative cases from the first trimester combined screening programme for Down syndrome? Curr Opin Obstet Gynecol 2014;26:110–16
   PubMed Web of Science ®Google Scholar
• Schmidt P, Pruggmayer M, Steinborn A, et al. Are nuchal translucency, pregnancy associated plasma protein-A or free-beta-human chorionic gonadotropin depending on maternal age? A multicenter study of 8,116 pregnancies. Arch Gynecol Obstet 2007;276:259–62
   PubMedGoogle Scholar
• Gebb J, Dar P. Should the first-trimester aneuploidy screen be maternal age adjusted? Screening by absolute risk versus risk adjusted to maternal age. Prenat Diagn 2009;29:245–7
   PubMed Web of Science ®Google Scholar
• Engels MAJ, Twisk JWR, Blankenstein MA, et al. Age independent first trimester screening for Down syndrome: improvement in test performance. Prenat Diagn 2013;33:884–8
   PubMed Web of Science ®Google Scholar
• Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006;108:1067–72
   PubMed Web of Science ®Google Scholar
• Marttala J, Kaijomaa M, Ranta J, et al. False-negative results in routine combined first-trimester screening for Down syndrome in Finland. Am J Perinatol 2012;29:211–16
   PubMed Web of Science ®Google Scholar
• Simonsen TS, Sørensen S, Ekelund C, et al. Prenatal characteristics of false negative cases from first-trimester screening of Down syndrome (trisomy 21). Prenat Diagn 2013;33:400–2
   PubMed Web of Science ®Google Scholar
• Peuhkurinen S, Laitinen P, Ryynanen M, et al. First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age. J Eval Clin Pract 2013;19:324–6
   PubMed Web of Science ®Google Scholar
• Schmidt P, Hörmansdörfer C, Pruggmayer M, et al. Improved prenatal aneuploidy screening using the novel advanced first-trimester screening algorithm: a multicenter study of 10,017 pregnancies. J Clin Ultrasound 2008;36:397–402
   PubMed Web of Science ®Google Scholar